Abiopharma

🔍 Lynne Christopher Mark (Director)

Company: Phoenix Education Partners, Inc. (PXED)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 75,260 shares of Common Stock, par value $0.01 per share at $11.04 per share (Direct)
  Date: 2026-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 251,638.00 | transaction_form_type: 4
• Sold 45,249 shares of Common Stock, par value $0.01 per share at $28.74 per share (Direct)
  Date: 2026-08-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 206,389.00 | transaction_form_type: 4
• Sold 75,260 shares of Employee Stock Option (Right to Buy) at $11.04 per share (Derivative)
  Date: 2026-08-25 | Code: M | Expires: 2026-08-31 | Exercise: 2025-10-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The stock options granted under The University of Phoenix, Inc. Management Equity Plan (the "University Equity Plan") were exercised by the Reporting Person because such stock options were scheduled to expire prior to the expiration of certain restrictions on transfer of the Issuer's common stock by the Reporting Person, as previously disclosed in connection with the Issuer's initial public offering. The Reporting Person remains subject to such restrictions, which will expire on October 8, 2026. No shares of the Issuer's common stock were sold by the Reporting Person in connection with this transaction.